Multiple autoantigens in the prediction and pathogenesis of Type I diabetes

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 9, Issue 4, 1996, Pages 188-198

  Kawasaki, E ^a   Eisenbarth, G S ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Autoantibodies; Diabetes risk; Prediction insulin autoantigen; Type I diabetes

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; INSULIN; PHOGRIN; UNCLASSIFIED DRUG;

AUTOIMMUNITY; DIAGNOSIS; ETIOLOGY; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RADIOASSAY; REVIEW; SCREENING;

EID: 0029849210     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Eisenbarth G.S., Ziegler A., Colman P.: Pathogenesis of insulin-dependent (type I) diabetes mellitus. In: Weir, Kahn C.R., (Eds.), Joslin's diabetes mellitus. 13th ed. Philadelphia. Lea & Febiger. 1994 pp. 216-239.
2. Greenbaum C., Palmer J.P., Kuglin B., Kolb H., and Participating Laboratories: Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: Results of the fourth international workshop on the standardization of insulin autoantibody measurement. J. Clin. Endocrinol. Metab. 74 1040-1044. 1992.
3. Baekkeskov S., Aanstoot H., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P.: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990.
4. Castano L., Russo E., Zhou L., Lipes M.A., Eisenbarth G.S.: Identification and cloning of a granule autoantigen (carboxypeptidase H) associated with Type I diabetes. J Clin. Endocrinol. Metab. 73: 1197-1201, 1991.
5. Pietropaolo M., Castano L., Babu S., Buelow R., Martin S., Martin A., Powers A., Proclwka M., Naggert J., Leiter E.H., Eisenbarth G.S.: Islet cell autoantigen 69 kDa (ICA69): molecular cloning and characterization of a novel diabetes associated autoantigen. J. Clin. Invest. 92: 359-371, 1993.
6. Dotta F., Previti, M., Lenti L., Dionisi S., Casetta B., D'Erme M., Eisenbarth G., Di Mario U.: GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia 38: 1117-1121, 1995.
7. Rabin D.U., Pleasic S.M., Palmer-Cracker R., Shapiro J. A.: Cloning and expression of IDDM-specific human autoantigens. Diabetes 41: 183-186, 1992.
8. Lan M.S., Lu J., Goto Y., Notkins A.L.: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2. from human insulinoma. DNA and Cell Biology 13:505-514, 1994.
9. Wasmeier C., Hutton J.C.: Molecular cloning of an insulin secretory granule protein tyrosine phosphatase. Diabetologia 38: A69, 1995 (Abstract).
10. Atkinson M.A., Maclaren N.K.: Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 92: 1608-1616, 1993.
11. Bu D., Erlander M.G., Hitz B.C., Tillakaratne N.J.K., Kaufman D.L., Wagner-McPherson C.B., Evans G.A., Tobin A.J., Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl. Acad. Sci. (USA) 89: 2115-2119, 1992.
12. Erlander M.G., Tillakaratne N.J.K., Feldblum S., Patel N., Tobin A.J.: Two genes encode distinct glutamate decarboxylases with different responses to pyridoxal phosphate. Neuron 7: 91-100, 1991.
13. Kaufman D.L., Houser C.R., Tobin A.J.: Two forms of the gamnia-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56: 720-723, 1991.
14. Petersen J.S., Russel S., Marshall M.O., Kofod H., Buschard K., Cambon N., Karlsen A., Boel E., Hagopian W.A., Hejinaes K.R., Moody A., Dyrberg T., Lernmark A., Madsen O.D., Michelsen B.K.: Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42: 484-495, 1993.
15. Velloso L.A., Kampe O., Eizirik D.L., Hallberg A., Andersson A., Karlsson F.A.: Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic islets. Diabetologia 36: 39-46, 1993.
16. Kim J., Richter W., Aanstoot H.J., Shi Y., Fu Q., Rajotte R., Warnock G., Baekkeskov S.: Differential expression of GAD65 and GAD67 in human, rat and mouse pancreatic islets. Diabetes 42: 1799-1808, 1993.
17. Moersch F.P., Woltman H.W.: Progressive fluctuating muscular rigiditiy and spasm (stiff-man syndrome) report of a case and some observations in 13 other cases. Mayo Clin. Proc. 31: 421-427, 1956.
18. Blum P., Jankovic J.: Stiff-person syndrome: An autoimmune disease. Movement Disorder.1, 6: 12-20, 1991.
19. McEvoy KM: Stiff-man syndrome. Mayo Clin. Proc. 66: 300-304, 1991.
20. Solimena M., Folli F., Aparisi R., Pozza G., DeCamilli P.: Autoantibodies to GABA-ergic neurons and pancreatic beta cells in Stiff-Man syndrome. N. Engl. J. Med. 322: 1555-1560, 1990.
21. Solimena M., DeCamilli P.: Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-man syndrome and insulin-dependent diabetes mellitus. Trends in Neurosciences 14: 452-457, 1991.
22. Gorin F., Baldwin B., Tait R., Pathak R., Seyal M.: Stiffman syndrome: a GABAergic autoimmune disorder with autoantigenic heterogeneity. Ann. Neurol. 28: 711-714, 1990.
23. Baekkeskov S., Nielsen J.H., Marner B., Bilde T., Ludvigsson J., Lernmark A.: Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human islet cell proteins. Nature 298: 167-169, 1982.
24. Baekkeskov S., Landin M., Kristensen J.K., Srikanta S., Bruining G.J., Mandrup-Poulsen T., Beaufort C., Soeldner J.S., Eisenbarth G.S , Lindgren F., Sundquist G., Lernmark A.: Antibodies to a 64,000 M, human islet cell antigen precede the clinical onset of insulin dependent diabetes. J. Clin. Invest. 79: 926-934, 1987.
25. Atkinson M.A., Maclaren N.K., Scharp D.W., Lacy P.E., Riley W.J.: 64000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335: 1357-1360, 1990.
26. Velloso L.A., Kampe O., Hallberg A., Christmanson L., Betsholtz C., Karlsson F.A.: Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in Type I diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J. Clin. Invest. 91: 2084-2090, 1993.
27. Hagopian W.A., Michelsen B., Karlsen A.E., Larsen F., Moody A., Grubin C.E., Rowe R., Petersen J., McEvoy R., Lernmark A.: Autoantibodies in IDDM primarily recognize the 65,000-Mr rather than the 67,000-Mr isoform of glutamic acid decarboxylase. Diabetes 42: 631-636, 1993.
28. Mauch L., Abney C.C., Berg H., Scherbaum W.A., Liedvogel B., Northemann W.: Characterization of a linear epitope within the human pancreatic 64-kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin-dependent diabetes mellitus patients. Eur. J. Biochem. 212: 597-603, 1993.
29. Tuomi T., Rowley M.J., Knowles W.J., Chen Q.Y., McAnally T., Zimmet P.Z., Mackay I.R.: Autoantigenic properties of native and denatured glutamic acid decarboxylase. evidence for a conformational epitope. Clin. Immunol. Immunopathol. 71: 53-59, 1994.
30. Daw K., Powers A.C.: Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes 44: 216-220, 1995.
31. Daw K., Ujihara N., Atkinson M., Powers A.C.: Glutamic acid decarboxylase autoantibodies in Stiff-man syndrome and insulin-dependent diabetes meilitus exhibit similarities and differences in epitope recognition. J. Immunol. 156: 818-825, 1996.
32. Pugliese A., Gianani R., Moromisato R., Awdeh Z.L., Alper C A., Erlich H.A., Jackson R.A., Eisenbarth G.S.: HLADQB1 0602 is associated with dominant protection from diabetes even among isiet cell antibody positive first degree relatives of patients with insulin-dependent diabetes. Diabetes 44: 608-613, 1995.
33. Ujihara N., Daw K., Gianani R., Boel E., Yu L., Powers A.C. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in Type I diabetes. Diabetes 43: 968-975, 1994.
34. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V.: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72, 1993.
35. Tisch R., Yang X., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O.: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75, 1993.
36. Harrison L.C., Honeyman M.C., De Aizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S.: Inverse relationship between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365-1369, 1993.
37. Atkinson M.A., Kaufman D.L., Campbell L., Gibbs K.A., Shah S.C., Ding-Fang B., Erlander M.G., Tobin A.J., Maclaren N.K.: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458-459, 1992.
38. Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oles J., Hicks J.M., Goldstein D.E., Rae P.M.M.: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol 152: 3183-3187, 1994.
39. Gianani R., Rabin D.U., Verge C.F., Yu L., Babu S., Pietropaolo M., Eisenbarth G.S.: ICA512 autoantibody radioassay. Diabetes 44: 1340-1344, 1995.
40. Kawasaki E., Yu L., Gianani R., Verge C.F., Babu S., Bonifacio E., Eisenbarth G.S.: Improved sensitivity of ICA512 autoantibody radioassay and efficiency of islet autoantibody screening. submitted 1996.
41. Christie M.R., Vohra G., Champagne P., Daneman D., Delovitch T.L.: Distinct antibody specificities to a 64-kD islet cell antigen in Type I diabetes as revealed by trypsin treatment. J. Exper. Med. 1990.
42. Payton M.A., Hawkes C.J., Christie M.R.: Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96: 1506-1511, 1995.
43. Bonifacio E., Lampasona V., Genovese S., Ferrari M., Bosi E.: Identification of protein tyrosine phosphaiase-like IA2 (islet call antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155: 5419-5426, 1995.
44. Kawasaki E., Eisenbarth G.S., Wasmeicr C., Hutton J.C.: Autoantibodies to protein tyrosine phosphatase-like proteins in Type I diabetes: Overlapping specificities to phogrin and ICA512/IA-2. Diabetes: in press 1996.
45. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L.: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339, 1983.
46. Castano L., Ziegler A., Ziegler R., Shoelson S., Eisenbarth G.S.: Characterization of insulin autoantibodies in relatives of patients with insulin-dependent diabetes mellitus. Diabetes 42: 1202-1209, 1993.
47. Vardi P., Dib S.A., Tuttleman M. Connelly J.E., Grinbergs M., Rabizadeh A., Riley W.J., Maclaren N.K., Eisenbanh G.S., Soeldner J.S.: Competitive insulin autoantibody RIA: Prospective evaluation of subjects at high risk for development of Type I diabetes mellitus. Diabetes 36: 1286-1291, 1987.
48. Vardi P., Ziegler A.G., Matthews J.H., Dib S., Keller R.J., Ricker A.T., Wolfsdorf J.I., Herskowitz R.D., Rabizadeh A., Eisenbarth G.S., Soeldner J.S.: Concentration of insulin autoantibodies at onset of Type I diabetes: inverse log-linear correlation with age. Diabetes Care 11: 736-739, 1988.
49. Wegmann D., Norbury-Glaser M., Daniel D.: Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Ear. J. Immunol. 24: 1853-1857, 1994.
50. Wegmann D.R., Gill R.G., Norbury-GIaser M., Schloot N., Daniel D.: Analysis of the spontaneous T cell response to insulin in NOD mice. J. Autoimmunity 7: 833-843, 1994.
51. Daniel D., Gill R.G., Schloot N., Wegmann D.: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056-1062, 1995.
52. Martino G.V., Tappaz M.L., Braghi S., Dozio N., Canal N., Pozza G., Bottazzo G.F.: Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies. J. Autoimmunity 4: 915-923, 1991.
53. Rowley M.J., Mackay I.R., Chen Q., Knowles W.J., Zimmet P.Z.: Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41: 548-551, 1992
54. Kawasaki E., Takino H., Yano M., Uotani S., Matsumoto K., Takao Y., Yamaguchi Y., Akazawa S., Nagataki S.: Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86, 1994.
55. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., Lernmark A.: A novel radiogland binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344-350, 1994.
56. Petersen J.S., Hejnaes K.R., Moody A., Karlsen A.E., Marshall M.O., Hoier-Madsen M., Boel E., Michelsen B., Dyrberg T.: Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43: 459-467, 1994.
57. DeAizpurua H.J., Harrison L.C., Cram D.S.: An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes 41: 1182-1187, 1992.
58. Schmidli R.S., Colman P.G., Bonifacio E. and Participating Laboratories: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb workshop. Diabetes 44: 636-640, 1995.
59. Bonifacio E., Bingley P.J. Shattock M., Dean B.M., Dunger D., Gale E.A.M., Bottazzo G.F.: Quantitative islet cell antibody measurement assists in the prediction of insulin-dependent diabetes. Lancet 335: 147-149, 1990.
60. Schatz D., Krischer J., Horne G., Riley W., Spillar R., Silverstein J., Winter W., Muir A., Derovanesian D., Shah S., Malone J., Maclaren N.: Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J. Clin. Invest. 93: 2403-2407, 1994.
61. Landin-Olsson M.: Precision of the islet-cell antibody assav depends on the pancreas. J. Clin. Lab. Annal. 4: 289-294, 1990.
62. Greenbaum C.J., Palmer J.P., Nagataki S., Yamaguchi Y., Molenaar J.L., Van Beers W.A.M.. Maclaren N.K., Lernmark A.: Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Exhange Workshop. Diabetes 41: 1570-1574, 1992,
63. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietroapolo M., Jackson R.A., Chase H.P., Eisenbarth G.S.: Prediction of Type I diabetes in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512 autoantibodies. Diabetes 45: 926-933, 1996.
64. Vardi P., Crisa L., Jackson R.A., Herskowitz R.D., Wolfsdorf J.I., Einhorn D., Linarelli L., Dolinar R., Wentworth S., Brink S.J., Starkman H., Soeldner J.S., Eisenbarth G.S.: Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type I (insulin-dependent) diabetic patients. Diabetologia 34: 93-102, 1991.
65. Diabetes Epidemiology Research Intl Mortality Study Group: Major cross-country differences in risk of dying for people with IDDM. Diabetes Care 14: 49-60, 1991.
66. LaPorte R.E., Matsushima M., Chang Y.: Prevalence and incidence of insulin-dependent diabetes. 37-45, 1995(Abstract).
67. Rewers M , Bugawan T.L., Norris J.M., Blair A., Beaty B., Hoffman M., McDuffie R.S., Hamman R.F., Khngensmith G., Eisenbarth G.S., Erlich H.A.: Newborn screening for HLA markers associated with IDDM: Diabetes Autoimrnunity Study in the Young (DAISY). Diabetologia 1996 (In Press).
68. Warram H.H., Krolewski A.S., Gottlieb M.S., Kahn C.R.: Differences in nsk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N. Engl. J. Med 311: 149-152, 1984.
69. Tillil H., Kobberling J.: Age-correlated empirical genetic risk estimates for first degree relatives of IDDM patients. Diabetes 36: 93-99, 1987.
70. Bleich D., Polak M., Eisenbarth G.S., Jackson R.A.: Decreased risk of Type I diabetes in offspring of mothers who acquire diabetes durins adrenarchy. Diabetes 42: 1433-1439, 1993.
71. Yu L., Chase H.P., Falorni A., Rewers M., Lernmark A., Eisenbarth G.S.: Sexual dimorphism in transmission of expression of islet autoantibodies to offspring. Diabetologia 38: 1353-1357, 1995.
72. Vandewalle C.L., Falorni A., Svanholm S., Lernmark A., Pipeleers D.G., Gorus F.K. and the Belgian Diabetes Registry: High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J. Clin. Endocrinol. Metab. 80: 846-851, 1995.
73. Nepom G.T.: A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 39: 1153-1157, 1990.
74. Baisch J.M., Week T., Giles, R., Hoover M., Stastny P., Capra D.: Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322: 1836-1841, 1990.
75. Sheehy M.J.: HLA and insulin-dependent diabetes. Diabetes 41: 123-129, 1992.
76. Ziegler R., Alper CA., Awdeh Z.L., Castano L., Brink S.J., Soeldner J.S., Jackson R.A., Eisenbarth G.S.: Specific association of HLA-DR4 with incresased prevalence and level of insulin autoantibodies in first degree relatives of patients with Type I diabetes. Diabetes 40: 709-714, 1991.
77. Ziegler A.G., Standl E., Albert E., Mehnert H.: HLA-associated insulin autoantibody formation in newly diagnosed Type I diabetic patients. Diabetes 40: 1146-1149, 1991.
78. Vandewalle C.L., Decraene T., Schuit F.C., De Leeuw I.H., Pipeleers D.G., Gorus F.K.: Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA*0301-DQB 1*0302 haplotype at clinical onset of Type I (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. Diabetologia 36: 1155-1162, 1993.
79. Gorus F.K., Vandewalle C.L., Dorchy H., Crombrugge P.V., Schuit F.C., Pipeleers D.G.: Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DQA1 *0301-DQB 1*0302 in siblings of patients with Type I (insulin-dependent) diabetes mellitus. J. Clin. Endocrinol. Metab. 1172-1 178, 1994.
80. Pugliese A., Bugawan T., Moromisato R., Awdeh Z.L., Alper C.A., Jackson R.A., Erlich H.A., Eisenbarth G.S.: Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes. J. Clin. Invest. 93: 2447-2452, 1994.
81. Todd J.A., Bell J.I., McDevitt H.O.: HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604, 1987.
82. Erlich H.A., Bugawan T.L., Scharf S., Nepom G.T., Tait B., Griffith R.L.: HLA-DQB sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39: 96-103, 1990.
83. Baisch J.M., Weeks T., Giles R., Hoover M., Stastny P., Capra J.D.: Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med 322: 1836-1841, 1990.
84. - first degree relatives of patients with Type I diabetes expressing the HLA DQB1*0602 allele. J. Autoimmunity 9: 423-426, 1996.
85. Keller R.J., Eisenbarth G.S., Jackson R.A.: Insulin prophylaxis in individuals at high risk of Type I diabetes. Lancei 341: 927-928, 1993.
86. Eisenbarth G.S., Jackson R.A., Pugliese A.: Insulin autoimmunity: the rate limiting factor in pre-Type I diabetes. J. Autoimmunitry 5 (Suppl A): 241-246, 1992.
87. Ziegler A.G., Ziegler R., Vardi P., Jackson R.A., Soeldner J.S., Eisenbarth G.S.: Life table analysis of progression to diabetes of anti-insulin autoantibody positive relatives of individuals with Type I diabetes. Diabetes 38: 1320-1325. 1989.
88. Sochett E., Daneman D.: Relationship of insulin autoantibodies to presentation and early course of IDDM in Children. Diabetes Care 12: 517-523, 1989.
89. Arslanian S.L., Becker D.J., Rabin B., Atchison R., Eberhardt M., Cavender D., Dorman J., Drash A.L.: Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 34: 926-930, 1985.
90. Ludvigsson J., Binder C., Mandrup-Poulsen T.: Insulin autoantibodies are associated with islet cell antibodies: their relation to insulin antibodies and B cell function in diabetic children. Diabetologia 31: 647-651, 1988.
91. Julier C., Hyer R.N., Davies J., Merlin F., Soularue P., Briant L., Cathelineau G., Deschamps L., Rotter J.I., Froguel P., Boitard C., Bell J.I., Lathrop G.M.: Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 354: 155-159, 1991.
92. Lucassen A.M., Julier C., Beressi J., Boitard C., Froguel P., Lathrop M., Bell J.I.: Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nature Genet. 4: 305-310, 1993.
93. Owerbach D., Gabbay K.H.: Localization of a type 1 diabetes susceptibility locus to the variable tandem repeat region fianking the insulin gene. Diabetes 42: 1708-1714, 1993.
94. Zhang J.Z., Davidson L., Eisenbarth G.S , Weiner H.L.: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. (USA) 88: 10252-10256, 1991.
95. Bergerot I., Fabien N., Maguer V., Thivolet C.: Oral insulin induces CD4* regulatory cells that protect NOD mice from adoptive transfer of diabetes. J. Imnumol. 1994 (Abstract).
96. Maclaren N., Lafferty K.: Perspectives in Diabetes: The 12th international immunology and diabetes workshop. Diabetes 42: 1099-1104, 19937
97. Muir A., Peck A., Clare-Salzler M., Yao-Hua S., Cornelius J., Luchetta R., Krischer J., Maclaren N.: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferongamma transcription. J. Clin. Invest. 95: 628-634, 1995.
98. Daniel D., Wegmann D.R.: Protection of NOD mice from diabetes by intranasal or subcutaneous administration of insulin peptide B:9-23. Proc. Natl. Acad. Sci. 1995(In Press).